Correction to: c-Src confers resistance to mitotic stress through inhibition of DMAP1/Bub3 complex formation in pancreatic cancer

被引：0
|
作者：
Jingjie Li
Bin Hu
Ting Wang
Wenhua Huang
Chunmin Ma
Qin Zhao
Lingang Zhuo
Tao Zhang
Yuhui Jiang
机构：
[1] Shanghai General Hospital,The Institute of Cell Metabolism, Shanghai Key Laboratory of Pancreatic Disease
[2] Shanghai Jiaotong University,Department of Gastroenterology
[3] School of Medicine,Department of Pharmacology, College of Basic Medical Sciences
[4] Shanghai General Hospital,Department of Orthopedics
[5] Shanghai Jiao Tong University,undefined
[6] School of Medicine,undefined
[7] Tianjin Medical University,undefined
[8] Shanghai General Hospital,undefined
[9] Shanghai Jiao Tong University,undefined
[10] School of Medicine,undefined
来源：
Molecular Cancer | / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following publication of the work [1], authors reported the “flow cytometery plots” panel in Fig. 4e contained an inter-duplication in error.
引用
收藏
相关论文
共 5 条
  • [1] C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer
    Li, Jingjie
    Hu, Bin
    Wang, Ting
    Huang, Wenhua
    Ma, Chunmin
    Zhao, Qin
    Zhuo, Lingang
    Zhang, Tao
    Jiang, Yuhui
    MOLECULAR CANCER, 2018, 17
  • [2] C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer
    Jingjie Li
    Bin Hu
    Ting Wang
    Wenhua Huang
    Chunmin Ma
    Qin Zhao
    Lingang Zhuo
    Tao Zhang
    Yuhui Jiang
    Molecular Cancer, 17
  • [3] c-Src confers resistance to mitotic stress through inhibition of DMAP1/Bub3 complex formation in pancreatic cancer (vol 17, 174, 2018)
    Li, Jingjie
    Hu, Bin
    Wang, Ting
    Huang, Wenhua
    Ma, Chunmin
    Zhao, Qin
    Zhuo, Lingang
    Zhang, Tao
    Jiang, Yuhui
    MOLECULAR CANCER, 2019, 18 (01)
  • [4] The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling
    Fatemeh Safari
    Nasim Shafiee Nejad
    Azadeh Aghaei Nejad
    Medical Oncology, 2022, 39
  • [5] The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling
    Safari, Fatemeh
    Shafiee Nejad, Nasim
    Aghaei Nejad, Azadeh
    MEDICAL ONCOLOGY, 2022, 39 (03)
1